My Quote Request
No products added yet
6505-00-007-8296
20 Products
NDC00998-0331-05
SCOPOLAMINE HYDROBROMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505000078296
NSN
6505-00-007-8296
NDC00998-0331-05
SCOPOLAMINE HYDROBROMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505000078296
NSN
6505-00-007-8296
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENT 0.25 PCT SCOPOLAMINE HYDROBROMIDE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SCOPOLAMINE HYDROBROMIDE OPHTHALMIC SOLUTION USP 0.25% 5ML BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ALCON LABS INC
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: PLASTIC BOTTLE W/OPHTHALMIC TIP
Related Searches:
NDC00093-4175-73
CEPHALEXIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505000091833
NSN
6505-00-009-1833
NDC00093-4175-73
CEPHALEXIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505000091833
NSN
6505-00-009-1833
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 GRAMS CEPHALEXIN EQUIVALENT
ADMINISTRATION: ORAL
FLAVOR: PALATABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALEXIN FOR ORAL SUSPENSION USP 125 MG PER 5ML 100ML
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE W/CHILD-PROOF SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 100 ML W/ADEQUATE SHAKE SPACE; EQUIVALENT TO 125 MG CEPHALEXIN PER 5 ML WHEN RECONSTITUTED TO 100 ML
Related Searches:
NDC00524-0021-16
POTASSIUM GLUCONATE AND POTASSIUM CITRATE ELIXIR
NSN, MFG P/N
6505000091843
NSN
6505-00-009-1843
NDC00524-0021-16
POTASSIUM GLUCONATE AND POTASSIUM CITRATE ELIXIR
NSN, MFG P/N
6505000091843
NSN
6505-00-009-1843
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIEQUIVALENTS POTASSIUM GLUCONATE PER MILLILITER AND 0.300 MILLIEQUIVALENTS POTASSIUM CITRATE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TWIN-K
POTASSIUM GLUCONATE AND POTASSIUM CITRATE ELIXIR
NSN, MFG P/N
6505000091843
NSN
6505-00-009-1843
TWIN-K
POTASSIUM GLUCONATE AND POTASSIUM CITRATE ELIXIR
NSN, MFG P/N
6505000091843
NSN
6505-00-009-1843
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIEQUIVALENTS POTASSIUM GLUCONATE PER MILLILITER AND 0.300 MILLIEQUIVALENTS POTASSIUM CITRATE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MYOFLEX
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
MYOFLEX
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 10.000 TRIETHANOLAMINE SALICYLATE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES OR 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
Related Searches:
MYOFLEX CREAM
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
MYOFLEX CREAM
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 10.000 TRIETHANOLAMINE SALICYLATE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES OR 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
Related Searches:
NDC00013-5404-61
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
NDC00013-5404-61
TRIETHANOLAMINE SALICYLATE CREAM
NSN, MFG P/N
6505000091858
NSN
6505-00-009-1858
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE INGREDIENT AND STRENGTH: 10.000 TRIETHANOLAMINE SALICYLATE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES OR 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
Related Searches:
2B7357
SORBITOL SOLUTION,MODIFIED
NSN, MFG P/N
6505000091860
NSN
6505-00-009-1860
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3 PCT SORBITOL
ADMINISTRATION: IRRIGATION
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
2B1094
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094951
NSN
6505-00-009-4951
2B1094
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094951
NSN
6505-00-009-4951
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENTS 5 PCT DEXTROSE,0.2 PCT SODIUM CHLORIDE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00015-9161-87
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094957
NSN
6505-00-009-4957
NDC00015-9161-87
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094957
NSN
6505-00-009-4957
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 PCT LIDOCAINE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 - 22 GAGE BY 1-1/2INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00469-9161-87
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094957
NSN
6505-00-009-4957
NDC00469-9161-87
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094957
NSN
6505-00-009-4957
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 PCT LIDOCAINE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 - 22 GAGE BY 1-1/2INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00015-9422-78
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094968
NSN
6505-00-009-4968
NDC00015-9422-78
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000094968
NSN
6505-00-009-4968
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V CALCIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 22 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PD2
LINDANE CREAM,USP
NSN, MFG P/N
6505000094996
NSN
6505-00-009-4996
MFG
PUBLIC HEALTH SERVICE SPECIFICATIONS PROMULGATED BY PUBLIC HEALTH SERVICE WASHINGTON DC
Description
MANUFACTURERS CODE: 24061
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: PD2
PRIMARY CONTAINER CONTENT QUANTITY: 180.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH:10.000 GRAMS SODIUM FLUORIDE
Related Searches:
R1210
SODIUM CHLORIDE IRRIGATION,MODIFIED
NSN, MFG P/N
6505000094998
NSN
6505-00-009-4998
R1210
SODIUM CHLORIDE IRRIGATION,MODIFIED
NSN, MFG P/N
6505000094998
NSN
6505-00-009-4998
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.450 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1035-89
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095060
NSN
6505-00-009-5060
NDC00182-1035-89
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095060
NSN
6505-00-009-5060
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.400 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.042 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.42 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG I.S. 100 CAPULES/PACKAGE
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES
Related Searches:
NDC00069-0950-73
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
NDC00069-0950-73
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
MFG
PFIZER INC. DBA PFIZER
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.11 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.058 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.92 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG 500 CAPSULES PER BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00143-3142-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
NDC00143-3142-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.11 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.058 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.92 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG 500 CAPSULES PER BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00364-2033-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
NDC00364-2033-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.11 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.058 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.92 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG 500 CAPSULES PER BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00536-0230-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
NDC00536-0230-05
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
MFG
RUGBY GROUP INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.11 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.058 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.92 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG 500 CAPSULES PER BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00603-3481-28
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
NDC00603-3481-28
DOXYCYCLINE HYCLATE CAPSULES,USP
NSN, MFG P/N
6505000095063
NSN
6505-00-009-5063
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.11 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 7.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.058 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.92 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOXYCYCLINE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOXYCYCLINE HYCLATE CAPSULES USP 100 MG 500 CAPSULES PER BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
